Naoki Niikura, MD, PhD, discusses the impact of treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer with brain metastases and/or leptomeningeal disease, as evaluated in the real-world ROSET-BM study in Japan.
TANAKA Contributes To Global Vascular, A Medical Venture Company Developing A Stent Delivery System For Lower Limb Atherosclerosis menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
TANAKA Contributes to Global Vascular, a Medical Venture Company Developing a Stent Delivery System for Lower Limb Atherosclerosis jcnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jcnnewswire.com Daily Mail and Mail on Sunday newspapers.